Sun Pharmaceutical’s shares fell over 3% amid acquisition concerns regarding Organon & Co.
Categories
Market MonitorSharing updates and insights on stock, gold, and crypto markets with advertising opportunities.
Market MonitorSun Pharmaceutical’s shares fell over 3% amid acquisition concerns regarding Organon & Co.